Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
-14,283,438
Put/Call ratio
20%
SEC-reported price per share
$35.28
Number of holders
484
Value change
-$513,196,140
Number of buys
292
Open additional details 1 more signal available
Number of sells
183
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
445,144,313

Security key

G7709Q104

Report period

Q3 2025

Institutions

484

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Legorreta G. Pablo
Disclosed value leader
Legorreta G. Pablo
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F 3/4/5 Lead comparable stake: 20% 13D/G row: Legorreta G. Pablo Showing 1-6 of 15 holder rows.

Quick read

Legorreta G. Pablo leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Legorreta G. Pablo's linked filing trail.
Comparable ownership Top 5
Legorreta G. Pablo 20%
MORGAN STANLEY 9.2%
FMR LLC 6.5%
BlackRock, Inc. 5.7%
GENERAL ATLANTIC, L.P. 3.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Legorreta G. Pablo
13D/G
20%
$3,372,819,557
103,112,796 shares
$0 16 May 2025
MORGAN STANLEY
13F 13D/G
Company
9.2%
from 13D/G
$1,679,145,924
46,604,103 shares
30 Jun 2025
FMR LLC
13F 13D/G
Company
6.5%
from 13D/G
$1,454,092,272
40,357,821 shares
30 Jun 2025
BlackRock, Inc.
13F 13D/G
Company
5.7%
from 13D/G
$916,201,678
25,428,856 shares
30 Jun 2025
GENERAL ATLANTIC, L.P.
13D/G 13F
Company
3.2%
$510,500,301
14,243,870 shares
$0 30 Jun 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
2.5%
from 13D/G
$1,310,687,739
36,377,678 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
484
Shares
327,857,254
Rows available
484
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
452
Q3 2025 holders
484
Holder diff
32
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .